Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04080180 · ClinicalTrials.gov registry record · NA
SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence
A NA study of Opioid Use Disorder, sponsored by Karen Derefinko, PhD.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
- 1
- Study location
NCT04080180 is a NA study of Opioid Use Disorder that has completed, run by Karen Derefinko, PhD. The registered enrollment target is 332 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04080180, a NA study of Opioid Use Disorder, has completed, sponsored by Karen Derefinko, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM).
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
- BEHAVIORAL Brief Motivational Interviewing + Substance Free Activities + Mindfulness
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04080180
The ClinicalTrials.gov registry entry for NCT04080180 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Karen Derefinko, PhD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management is the first listed.
NCT04080180 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT04080180 about?
NCT04080180 is a clinical study titled "SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence". The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM).
What is the current status of trial NCT04080180?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2022-02-01. Estimated completion is 2025-02-01.
What conditions does trial NCT04080180 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04080180?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BEHAVIORAL).
Who is sponsoring clinical trial NCT04080180?
This trial is sponsored by Karen Derefinko, PhD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04080180 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.